| 000 | 01758 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516103640.0 | ||
| 264 | 0 | _c20130103 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1873-2623 | ||
| 024 | 7 |
_a10.1016/j.transproceed.2012.04.025 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGokce, M | |
| 245 | 0 | 0 |
_aCilostazol and diltiazem attenuate cyclosporine-induced nephrotoxicity in rats. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _c |
||
| 300 |
_a1738-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 |
_aCatalase _xmetabolism |
| 650 | 0 | 4 | _aCilostazol |
| 650 | 0 | 4 | _aCyclosporine |
| 650 | 0 | 4 |
_aDiltiazem _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
| 650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMalondialdehyde _xmetabolism |
| 650 | 0 | 4 |
_aPhosphodiesterase 3 Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProtective Agents _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReperfusion Injury _xchemically induced |
| 650 | 0 | 4 |
_aSuperoxide Dismutase _xmetabolism |
| 650 | 0 | 4 |
_aTetrazoles _xpharmacology |
| 700 | 1 | _aYuzbasioglu, M F | |
| 700 | 1 | _aBulbuloglu, E | |
| 700 | 1 | _aOksuz, H | |
| 700 | 1 | _aYormaz, S | |
| 700 | 1 | _aAltınoren, O | |
| 700 | 1 | _aKutlucan, M | |
| 700 | 1 | _aCoskuner, I | |
| 700 | 1 | _aSilay, E | |
| 700 | 1 | _aKale, I T | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 44 _gno. 6 _gp. 1738-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2012.04.025 _zAvailable from publisher's website |
| 999 |
_c21981622 _d21981622 |
||